[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

 First-Time Generics - August 2003

  Generic Drug Name Generic Manufacturer Brand Name Approval Date
1 AMOXICILLIN TABLETS FOR ORAL SUSPENSION 200 MG AND 400 MG RANBAXY LABORATORIES LIMITED AMOXIL FOR ORAL SUSPENSION 8/11/2003 
2 LIDOCAINE AND PRILOCAINE CREAM 2.5%/2.5%        ALTANA INC. EMLA CREAM 8/18/2003 
3 TRIMETHOBENZAMIDE HYDROCHLORIDE CAPSULES, USP 300 MG AMIDE PHARMACEUTICAL, INC. TIGAN CAPSULES 8/20/2003 
4 CEFPODOXIME PROXETIL TABLETS 100 MG (BASE) AND 200 MG (BASE) RANBAXY LABORATORIES, INC. VANTIN TABLETS 8/20/2003 
5 FAMOTIDINE TABLETS (CHEWABLE) (OTC) 10 MG L. PERRIGO COMPANY PEPCID-AC CHEWABLE TABLETS 8/22/2003 
6 SOTALOL HYDROCHLORIDE TABLETS (AF) 80 MG, 120 MG, AND 160 MG TORPHARM BETAPACE AF TABLETS 8/27/2003 
7 FLAVOXATE HYDROCHLORIDE TABLETS 100 MG IMPAX LABORATORIES, INC. URISPAS TABLETS 8/28/2003 
8 FLUDARABINE PHOSPHATE FOR INJECTION, USP 50 MG/SINGLE-DOSE VIAL SICOR PHARMACEUTICALS FLUDARA FOR INJECTION 8/28/2003 
9 HYDROCODONE BITARTRATE AND ACETAMINOPHEN ORAL SOLUTION 10 MG/500 MG PER 15 ML MALLINCKRODT INC. LORTAB ELIXIR 7/5 MG/500 MG PER 15 ML 8/29/2003 

Back to Top     Back to Approvals

Date created: 9/4/2003

horizonal rule